Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
about
Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature reviewTherapeutic implications of autoantibodies in rheumatoid arthritisUsing SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis.Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation.The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis.Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil.Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis.A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritisCurrent and future trends in biomarker discovery and development of companion diagnostics for arthritis.Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritisDiagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritisGrowth and infectious exposure during infancy and the risk of rheumatoid factor in adult life.Enhanced neutrophil phagocytic capacity in rheumatoid arthritis related to the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptides.Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope.Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritisA Seropositive Nodular Rheumatoid Polyarthritis without Arthritis: Does It Exist?Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis.Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA)Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis.Prevalence and associated factors of osteoporosis in female patients with rheumatoid arthritis.Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study.The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases.A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA.Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis.Inflammation and rheumatoid arthritis.Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.Testing for Rheumatological Diagnoses in Children.Reductions in radiographic progression in early RA over 25-years: Changing contribution from RF in 2 multi-centre UK inception cohorts.Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab.Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis.The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study.Anti-citrullinated peptide antibodies in Sudanese patients with Leishmania donovani infection exhibit reactivity not dependent on citrullination.Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult population.The prevalence of rheumatoid factor isotypes and anti-cyclic citrullinated peptides in Malaysian rheumatoid arthritis patients.Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population.
P2860
Q24675281-4F57A2F9-ACDB-4F47-9EFD-3BC375DBAD33Q26744033-94EFCC07-B47E-42DB-AB2C-3579000FFF8EQ33328566-2A7FDD3D-AE2B-4EBA-9C72-04AF73AFF32BQ33811944-DDBBE8F9-4029-4D3A-A799-6FB39037B039Q33896470-7B878318-0DCE-4904-9276-242DBCA3D238Q34114546-226C3173-E8DE-4F57-971E-927F68C009AFQ34349960-6928E3C6-A863-4D71-A297-8CA9ECB85C31Q34367709-F3C566AE-9E60-465B-989B-E60C2E3BF889Q34460622-E7CBEA34-6EFE-4F16-8C3A-9C5E855638B7Q35207886-29ADE4F1-C797-49B1-8986-BCAF43234DEFQ35470652-CFC46F40-10FB-4383-BF7D-949762E379DCQ35555882-E52B3B31-FCB9-4828-B65D-CE29B21C96ABQ35605590-290D8C06-BE40-486E-8AD4-922455BA2502Q35636850-496656C2-345A-4EDC-AF37-8CE72D12D58DQ35677937-F5CC9603-92AF-4E6F-A1BC-13B39DF2D692Q35751704-E6EDB9EE-E933-47DD-90AA-26FB171D32FEQ35760017-F9889BA3-07AA-400C-BE66-BF818CACA623Q35808002-115DB182-EEBF-4BE8-A788-A4DF9A4B49D9Q35915436-69250D03-5B59-4548-B7F9-EA03884BE781Q36395509-1FF761B1-DBD1-4CC8-9424-5735B39E0DE5Q37053019-922E3938-72AA-4546-82D5-5CD933B7D6ABQ37126187-D33974B4-F014-4075-A8DD-0DD2A15A2FF8Q37128520-6A1C829B-CA9E-476D-B4E6-608A3AE14A3EQ37228064-3417C2CC-2DE9-4CD7-B8B4-268A68F72082Q37280952-1C82970C-E16B-45DD-AB7B-E16D164C3E8CQ37480830-ED292E56-7A41-4A08-BB7D-1E9EA649F13DQ37624583-B3820224-BBFD-4198-A157-C72BC7EB26EDQ37707130-9D7E0508-E18E-4C10-9278-CA3839FC9113Q38079456-6AAABEE0-1933-4998-95B9-8D450695658BQ38855074-E5BB8638-33B9-4B25-99D6-F8B3FA4FE850Q38926303-D290F53B-D56C-4AB3-A46D-0FCB14497C15Q38952206-06CC600C-87AC-4CD3-B1AE-0F34F8CD6450Q39365604-62E5E147-05DD-4F78-A87F-B69C62BF4162Q39920872-640451AB-6639-46A0-96C6-2299C0524D60Q41228105-3151B2F9-6C1A-44D8-B37C-5C5F4D07DB4AQ41559282-A3B3E26E-3559-4F7F-9071-29CC01F44C35Q42667045-1B4C4E9F-3E03-42B1-85D5-6D538AE89C89Q43687288-36C9FFC5-0E42-401C-A5AD-F438F5E2FD41Q46555455-7D27D3D3-20B0-4760-A694-5027FB252204Q47656604-7BC4BC92-1625-4FED-900B-CABEA4C9E8B7
P2860
Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Diagnostic and clinical value ...... types in rheumatoid arthritis.
@ast
Diagnostic and clinical value ...... types in rheumatoid arthritis.
@en
type
label
Diagnostic and clinical value ...... types in rheumatoid arthritis.
@ast
Diagnostic and clinical value ...... types in rheumatoid arthritis.
@en
prefLabel
Diagnostic and clinical value ...... types in rheumatoid arthritis.
@ast
Diagnostic and clinical value ...... types in rheumatoid arthritis.
@en
P2093
P2860
P356
P1476
Diagnostic and clinical value ...... otypes in rheumatoid arthritis
@en
P2093
P2860
P304
P356
10.1136/ARD.2003.019877
P407
P50
P577
2004-09-01T00:00:00Z